172 related articles for article (PubMed ID: 25860237)
1. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy.
Akhtari M; Reddy JP; Pinnix CC; Allen PK; Osborne EM; Gunther JR; Milgrom SA; Smith GL; Wogan CF; Fowler N; Rodriguez MA; Dabaja B
Leuk Lymphoma; 2016; 57(1):34-8. PubMed ID: 25860237
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy in the management of localized primary cutaneous B-cell lymphoma.
Pashtan I; Mauch PM; Chen YH; Dorfman DM; Silver B; Ng AK
Leuk Lymphoma; 2013 Apr; 54(4):726-30. PubMed ID: 22916994
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma.
Eich HT; Eich D; Micke O; Süttzer H; Casper C; Krieg T; Müller RP
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):899-906. PubMed ID: 12605967
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
[TBL] [Abstract][Full Text] [Related]
5. Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa.
Vandersee S; Terhorst D; Humme D; Beyer M
J Am Acad Dermatol; 2014 Apr; 70(4):709-715. PubMed ID: 24433874
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Daniëls LA; Neelis KJ; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Velstra B; Veraart JCJM; Roach REJ; Vermeer MH; Quint KD
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1279-1285. PubMed ID: 28958772
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous B-cell lymphoma].
Cortés B; Prins C
Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
[TBL] [Abstract][Full Text] [Related]
8. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma.
Oertel M; Elsayad K; Weishaupt C; Steinbrink K; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):126-131. PubMed ID: 31758232
[TBL] [Abstract][Full Text] [Related]
9. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience.
De Felice F; Grapulin L; Pieroni A; Salerno F; D'Elia GM; Pulsoni A; Musio D; Tombolini V
Ann Hematol; 2018 Dec; 97(12):2411-2416. PubMed ID: 30094511
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.
Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN
Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of primary cutaneous B-cell lymphomas].
Zenahlik P; Fink-Puches R; Kapp KS; Kerl H; Cerroni L
Hautarzt; 2000 Jan; 51(1):19-24. PubMed ID: 10663035
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary cutaneous B-cell lymphoma with radiotherapy.
Ulutin HC; Oztürk B; Ongürü O; Kuzhan O; Arpaci F; Ozet A
Radiat Med; 2005 Jun; 23(4):292-5. PubMed ID: 16012406
[TBL] [Abstract][Full Text] [Related]
14. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous B-cell lymphomas. Current concepts. I.
Santucci M; Pimpinelli N
Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
19. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
